COMPOUNDS AND METHODS FOR KINASE MODULATION AND INDICATIONS FOR USE OF SAID COMPOUNDS AND METHODS Russian patent published in 2013 - IPC C07D213/75 C07D215/38 C07D231/40 C07D261/14 C07D285/16 C07D401/12 C07D407/12 C07D413/12 C07D417/12 C07D471/04 A61K31/165 A61K31/437 A61K31/444 A61K31/47 A61K31/5377 A61P35/00 

Abstract RU 2487121 C2

FIELD: chemistry.

SUBSTANCE: disclosed is a compound having chemical formula or a salt thereof, where: Ar is an optionally substituted heteroaryl; R1 in each case is independently selected from a group which includes halogen, lower alkyl, optionally substituted with one or more substitutes selected from fluorine, lower alkoxy, fluorine-substituted lower alkoxy, monoalkylamino, dialkylamino, -O-R5, -N(R5)-R6 and -N(R5)-C(X)-R7; m equals 0 or 1; n equals 0, 1 or 2; R2 is hydrogen or a halogen; L2 is -S(O)2-; R3 is a lower alkyl, optionally substituted with fluorine, C3-6 cycloalkyl, optionally substituted with a lower alkyl, a 5- or 6-member nitrogen-containing heterocycloalkyl, optionally substituted with one or more substitutes selected from fluorine, lower alkyl, fluorine-substituted lower alkyl, lower alkoxy, fluorine-substituted lower alkoxy, lower alkylthio or fluorine-substituted lower alkylthio, aryl, optionally substituted with a halogen, lower alkyl, optionally substituted with a halogen or lower alkoxy, optionally substituted with a halogen, or a heteroaryl, optionally substituted with a halogen or a lower alkyl; L1 is selected from a group which includes -O-, -C(R12R13)-X-, -X-C(R12R13)-, -C(R12R13)-N(R11)-, -(R11)-C(R12R13)-, -C(X)-N(R11)-, -N(R11)-C(X)-; X is O; R11 is hydrogen; R4 is hydrogen or a lower alkyl; R5 and R6 in each case are independently selected from a group which includes hydrogen, lower alkyl, cycloalkyl, heterocycloalkyl, aryl and heteroaryl, where each is optionally substituted with one or more substitutes selected from fluorine, lower alkoxy, fluorine-substituted lower alkoxy, lower alkylthio, fluorine-substituted lower alkylthio, monoalkylamino, dialkylamino; R7 in each case is independently selected from a group which includes lower alkyl; where the terms "lower alkyl", "lower alkoxy", "lower alkylthio", "monoalkylamino", "dialkylamino", "cycloalkyl", "heterocycloalkyl", "aryl", "heteroaryl", are as described in the claim. The invention also discloses a pharmaceutical composition for treating Raf kinase mediated diseases which is based on a compound of formula I; use of the compound of formula I to produce a medicinal agent is also disclosed.

EFFECT: novel compound which can be useful in treating diseases and conditions associated with aberrant activity of protein kinases is obtained and described.

9 cl, 13 ex, 2 tbl

Similar patents RU2487121C2

Title Year Author Number
PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS 2006
  • Ibrakhim Prabkha N.
  • Artis Din R.
  • Bremer Rajan
  • Mamo Shumeje
  • Nespi Marika
  • Zhang Chao
  • Zhang Dzhiazhong
  • Zhu Jong-Liang
  • Tsaj Dzhejms
  • Khert Klaus-Piter
  • Bollag Gideon
  • Spevak Uehjn
  • Cho Khanna
  • Dzhillet Sehm'Juehl Dzh.
  • Vu Guoksiam
  • Zhu Khong'Jao
  • Shi Shengkhua
RU2565071C2
PYROLLO [2,3-B]PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS 2012
  • Ibrahim Prahbha N.
  • Artis Dean R.
  • Bremer Ryan
  • Mamo Shumeye
  • Nespi Marika
  • Zhang Chao
  • Zhang Jiazhong
  • Zhu Yong-Liang
  • Tsai James
  • Hirth Klaus-Peter
  • Bollag Gideon
  • Spevak Wayne
  • Cho Hanna
  • Gillette Samuel J.
  • Vu Guoksiam
  • Zhu Khongyao
  • Shi Shengkhua
RU2629999C2
KINASES MODULATION AND INDICATIONS FOR ITS USE 2012
  • Chzhan Chao
  • Bollag Gideon
  • Khabets Gaston
  • Chzhan Tszyachzhun
  • Ibrakhim Prabkha N.
  • Vu Gosyan
RU2631487C2
PYRROLO[2,3-B]PYRIDINE DERIVATIVE AS PROTEIN KINASE INHIBITORS 2006
  • Ibrakhim Prabkha N.
  • Artis Din R.
  • Bremer Rajan
  • Mamo Shumeje
  • Nespi Marika
  • Zhang Chao
  • Zhang Dzhiazhong
  • Zhu Jong-Liang
  • Tsaj Dzhejms
  • Khert Klaus-Piter
  • Bollag Gideon
  • Spevak Uehjn
  • Cho Khanna
  • Dzhillet Sehm'Juehl Dzh.
  • Vu Guoksiam
  • Zhu Khong'Jao
  • Shi Shengkhua
RU2418800C2
COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY AND USE THEREOF 2007
  • Zhang Chao
  • Zhang Dzhiazhong
  • Ibrakhim Prabkha N.
  • Artis Din R.
  • Bremer Rajan
  • Vu Guoksian
  • Zhu Khong'Jao
  • Nespi Marika
RU2452738C2
HETEROCYCLIC COMPOUNDS AND USES THEREOF 2014
  • Chzhan Tszyayazhun
  • Buell Dzhon
  • Chan Katrina
  • Ibrakhim Prabkha N.
  • Lin Dzhek
  • Fam Fuongli
  • Shi Sonyuan
  • Spevak Vejn
  • Vu Guosyan
  • Vu Dzheffri
RU2680100C9
COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS 2009
  • Ueta Kiitiro
  • Arakava Kendzi
  • Matsusita Jasuaki
RU2481106C2
DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE 2014
  • Okhtake Josikhito
  • Okamoto Naoki
  • Ono Esiyuki
  • Kasivagi Khirotaka
  • Kimbara Atsusi
  • Kharada Takeo
  • Khori Nobuyuki
  • Murata Esikhisa
  • Tatibana Kadzutaka
  • Tanaka Sota
  • Nomura Keniti
  • Ide Mitsuaki
  • Midzuguti Ejsaku
  • Itida Yasukhiro
  • Okhtomo Suiti
  • Khoriba Naosi
RU2662832C2
COMPOUNDS AND METHODS FOR KINASE MODULATION AND INDICATIONS FOR THEIR USE 2013
  • Vu Guosyan
  • Chan Katrina
  • Eving Todd
  • Ibrakhim Prabkha N.
  • Lin Dzhek
  • Nespi Marika
  • Spevak Vejn
  • Chzhan In
RU2666146C2
COMPOUNDS FOR USE IN TREATMENT OF MUCOSITIS 2012
  • Skott Richard U.
  • Korchak Bozhena
RU2606128C2

RU 2 487 121 C2

Authors

U. Gosjan'

Chzhan Tszjachzhun

Chzhu Jun-Ljan

Chzhan Chao

Ibrakhim Prabkha N.

Shi Sunjuan'

Spevak Uehjn

Artis Din R.

Tsaj Dzhejms

Dates

2013-07-10Published

2008-07-16Filed